探索白内障:癌症幸存者的严重程度,功能能力和个人经历,通过混合方法分析
Deepika Ramalingam1, Theranirajan Ethiraj2, Shankar Shanmugam Rajendran3
1Department of Child Health Nursing, College of Nursing, Madras Medical College, The Tamil Nadu Dr. M.G.R. Medical University, Chennai, Tamil Nadu, India.
Journal of pharmacy & bioallied sciences
|June 13, 2025
概括
癌症缓解症对幸存者产生重大影响,导致严重的功能障碍. 解决这个问题需要一种整体的方法,结合身体,精神和生活方式的支持,以改善生活质量.
科学领域:
- 在瘤学瘤学.
- 临床营养学 临床营养学
- 生活质量研究 研究 生命质量研究
背景情况:
- 卡切西亚的特点是不自发的体重减轻和肌肉消耗,显著降低了癌症幸存者的生活质量和治疗结果.
- 了解白血病的多面影响对于制定有效的支持性护理策略至关重要.
研究的目的:
- 为了评估癌症幸存者的缓解症严重程度.
- 为了评估缓解症对幸存者的日常生活的功能影响.
- 为了探索癌症幸存者的经历,他们管理着缓解症.
主要方法:
- 一项混合方法,横截面研究与60名癌症幸存者在第三级护理中心进行.
- 使用Cachexia严重性评分和功能性评估厌食症/Cachexia治疗量表来收集定量数据.
- 通过对六名参与者进行半结构面试,收集了定性数据.
主要成果:
- 在缓冲症严重程度和功能能力之间发现了显著的负相关性 (r = -0.32,P = 0.01).
- 幸存者表现出显著的功能障碍,高缓解症严重程度得分 (平均:81.65) 和低功能能力得分 (平均7.10).
- 定性研究结果揭示了情绪和身体上的挑战,家庭支持和宗教信仰被认为是关键的应对机制.
结论:
- 卡切西亚对癌症幸存者构成重大多维挑战,影响身体功能和情感福祉.
- 有效的管理需要采用综合方法,包括身体康复,心理健康支持和生活方式调整.
- 整体的护理策略对于改善幸存者的生活质量和减轻白血病的普遍影响至关重要.
相关概念视频
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
01:20Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
01:24Kaplan-Meier Approach
111
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
111
01:20Actuarial Approach
68
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
68
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K